CMS Moves to Repeal Reimbursement for FDA-Approved Breakthrough Medical Devices
The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed repealing a rule that would have provided Medicare reimbursement for innovative medical technology approved under the U.S. Food and Drug Administration’s (FDA) Breakthrough Devices Program.